The SAFER-AUS trial is the Australian arm of the wider SAFER trial, which is being run by Cambridge University in conjunction with the NHS in the UK.
SAFER-AUS is being led by Professor Ben Freedman of the Heart Research Institute (HRI) & the University of Sydney. This study is being conducted nationally in collaboration with researchers from HRI, University of Tasmania, Curtin University and University of Notre Dame Australia.
This trial is investigating the use of handheld ECG screening devices within general practice (GP clinics) to detect undiagnosed Atrial Fibrillation (AF) in patients over 70 years old.
The trial aims to show that early detection of AF will decrease stroke in this patient group and if successful this trial would lead into a national screening program for early detection of AF.
SAFER-AUS Target Recruitment: 2,340